Radioligand Therapy: Targeted Cancer Treatment | Health and Fitness News

Radioligand therapy is a groundbreaking cancer treatment that delivers radiation directly to tumors using radioactive isotopes like lutetium-177, targeting specific receptors on cancer cells for precision strikes. Unlike traditional external beam radiation, this internal approach minimizes damage to healthy tissue. Approved in the U.S. as Pluvicto for metastatic prostate cancer, it involves six IV infusions spaced six weeks apart—quick, manageable, and similar to other intravenous treatments. After infusion, patients must follow strict safety protocols: drink plenty of fluids, avoid close contact with kids and pregnant women, sleep separately for days to weeks depending on who’s around, and practice hygiene like flushing toilets twice and washing hands often. While it requires temporary lifestyle adjustments, this targeted therapy offers hope for patients—and when side effects arise, medical teams are ready to help. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/c4994d66d640fbbc